Sleep Habits and Blood Sugar Control in Teenagers with Diabetes

Sleep and Glycemic Control in Type 2 Diabetes Adolescents

Recruiting N/A Interventional Study
Type 2 Diabetes
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
12 – 20
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
90 (estimated)
Sponsor
Children's Hospital of Philadelphia · Other
Who this trial is looking for

This trial is looking for teenagers aged 12-20 who have type 2 diabetes and want to improve their sleep. Participants will take part in activities related to their sleep patterns and how it affects their blood sugar control.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am between 12 and 20 years old.
  • I have been diagnosed with type 2 diabetes.
  • I have parental or guardian permission.
  • I have average sleep duration of less than 8 hours per night.
  • My blood sugar levels (HbA1c) are 10% or lower.

You may not be able to join if

  • I do not speak English.
  • I have type 1 diabetes.
  • I have a serious medical condition that affects my sleep.
  • I am currently pregnant.
  • I have been on steroid treatment in the past month.
  • I have obstructive sleep apnea or another sleep disorder.
  • I have a behavioral disorder that affects how I answer questions.
  • I cannot participate in activities using my phone or tablet.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The primary objective is to determine the cross-sectional relationship between sleep duration (as measured by 14 days of actigraphy) and glycemic control in an adolescent Type 2 Diabetes (T2DM) cohort (age 12-20y, n=67). A secondary objective is to determine if a loss-framed incentive for achieving sleep goals can increase sleep duration in 15 adolescent patients diagnosed with T2DM with insuffici…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Aim 1 for child: 1. Subjects age 12-20 2. Diagnosed with T2DM by standard laboratory criteria without pancreatic autoimmunity 3. Low probability of obstructive sleep apnea (OSA) assessed via validated sleep survey 4. Subjects will be included if they are taking T2DM treatments …
Contacts

Talia Hitt, MD/MPH

215-590-3174

hittt@chop.edu

CONTACT

Beth Schwartzman

215-590-3174

schwartzmann@chop.edu

CONTACT